Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2011-06-28

FDA Approved: MIRTAZAPINE — Supplemental Application (Mylan Pharmaceuticals Inc.)

View source ↗

Summary

FDA approved a supplemental application for mirtazapine submitted by Mylan Pharmaceuticals Inc. under an ANDA. This action confirms approval of the generic prod…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • mirtazapine (mirtazapine)

Snippet

SUPPL AP for MIRTAZAPINE (MIRTAZAPINE)